Charles River Laboratories (CRL): Director filed to sell ~$8.41M
FOSTER JAMES C, Director at Charles River Laboratories, filed to sell ~$8.41M of Charles River Laboratories shares.
- ~$8.41M
- planned to sell · 24K shares, around Oct 22, 2026
- Planned for
- Oct 22, 2026
- Notice filed
- Oct 22, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 28, 2026Federal contract · $5.3M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to date
- Aug 18, 2026Federal contract · $372K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $372K obligated to date
- Aug 25, 2026InsiderDirector sold ~$10.1M of CRL shares in the open market
- Aug 31, 2026Federal contract · $1.0M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $1.01M obligated to date
- Sep 8, 20265% stakeFMR LLC reported a passive stake (13G) of 10.2%
- Sep 17, 2026Federal contract · $2.7M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $2.68M obligated to date
- Sep 17, 2026Federal contract · $8.2M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $8.25M obligated to date
- Sep 25, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
- Oct 5, 2026InsiderOfficer sold ~$303K of CRL shares in the open market
- Oct 21, 2026InsiderOfficer sold ~$743K of CRL shares in the open market
- Oct 22, 2026InsiderDirector sold ~$8.41M of CRL shares in the open market
What came next
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Charles River Laboratories
For Charles River Laboratories, OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.
How this filing works
Explore the data
Other disclosures at Charles River Laboratories
- SEC Form 4Oct 26, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 144Oct 21, 2026
- SEC Form 4Oct 8, 2026
- SEC Form 144Oct 5, 2026
- USAspending.gov award recordSep 28, 2026
Everything OQRO holds on this company is on its CRL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
